Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex (SYNERGY)
Delayed visual evoked response in optic neuritis.
Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation.
Meta-analysis of adverse events in recent randomized clinical trials for dimethil fumarate, glatiramer acetate and teriflunomide for the treatment of relapsing forms of multiple sclerosis.
Episode 17 with Dr. Hans Lassmann on the usefulness of animal models for studying multiple sclerosis.
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis.
Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β1a in Relapsing-Remitting Multiple Sclerosis.
Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis.
Spectrophotometric Determination of Serum Copper with Biscyclohexanoneoxalyldihydrazone
MSGene
Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone).
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.
Long-term efficacy and safety of transanal irrigation in multiple sclerosis.
Cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis in the United States.
De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected.
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.
Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.
Episode 20 with Dr. Jeffrey Cohen discussing two MS-related clinical trials
Neuroprotection in a novel mouse model of multiple sclerosis.
Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking.
Request for Applications for Collaborative Network Awards from the Progressive MS Alliance
Episode 31 with Dr. Lloyd Kasper on the gut microbiome and MS
Episode 7 with Dr. Daniel Kantor on access to care
Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.
Keystone Symposium: Dendritic Cells and Macrophages Reunited

Pages